Financial News
Articles published by Edesa Biotech
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
Edesa Biotech to Present at ARDS Drug Development Summit
July 11, 2022
From Edesa Biotech
Via AccessWire
Tickers
EDSA
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
Edesa Biotech Appoints Strategy Expert to Board of Directors
March 29, 2022
From Edesa Biotech
Via AccessWire
Tickers
EDSA
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
Edesa Biotech Announces $10.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
March 22, 2022
From Edesa Biotech
Via AccessWire
Tickers
EDSA
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
Edesa Biotech Reports Enrollment Milestone in Phase 3 ARDS Study
February 17, 2022
From Edesa Biotech
Via AccessWire
Exposures
COVID-19
Tickers
EDSA
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
Edesa Biotech Reports Fiscal 1st Quarter 2022 Results
February 14, 2022
From Edesa Biotech
Via AccessWire
Exposures
COVID-19
Tickers
EDSA
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
Edesa Biotech to Join Ontario Bioscience Panel Discussion
January 26, 2022
From Edesa Biotech
Via AccessWire
Exposures
COVID-19
Tickers
EDSA
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
Edesa Biotech Reports Fiscal Year 2021 Results
December 28, 2021
From Edesa Biotech
Via AccessWire
Exposures
COVID-19
Tickers
EDSA
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
Edesa Biotech Marks Enrollment Milestone in Dermatitis Study
December 01, 2021
From Edesa Biotech
Via AccessWire
Topics
Intellectual Property
Tickers
EDSA
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
Edesa Biotech Extends COVID-19 Clinical Study to Poland
November 04, 2021
From Edesa Biotech
Via AccessWire
Topics
Intellectual Property
Tickers
EDSA
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg)
Edesa Biotech Announces Positive Phase 2 Data of Its Monoclonal Antibody in Hospitalized COVID-19 Patients
September 20, 2021
From Edesa Biotech
Via AccessWire
Topics
Intellectual Property
Tickers
EDSA
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg)
Edesa Biotech to Present at the H.C. Wainwright Global Investment Conference
September 09, 2021
From Edesa Biotech
Via AccessWire
Topics
Intellectual Property
Tickers
EDSA
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg)
Edesa Biotech Reports Fiscal 3rd Quarter 2021 Financial Results
August 13, 2021
From Edesa Biotech
Via AccessWire
Topics
Intellectual Property
Tickers
EDSA
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg)
Edesa Biotech Extends Dermatitis Study to Canada
July 13, 2021
From Edesa Biotech
Via AccessWire
Topics
Intellectual Property
Tickers
EDSA
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg)
Edesa Biotech Reports Favorable Review of COVID-19 Study
June 18, 2021
From Edesa Biotech
Via AccessWire
Topics
Intellectual Property
Tickers
EDSA
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg)
Edesa Biotech to Attend BIO Digital 2021
June 08, 2021
From Edesa Biotech
Via AccessWire
Topics
Intellectual Property
Tickers
EDSA
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg)
Edesa Biotech to Host Key Opinion Leader Webinar on EB05 for the Treatment of Acute Respiratory Distress Syndrome
April 22, 2021
From Edesa Biotech
Via AccessWire
Topics
Intellectual Property
Tickers
EDSA
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.